-
1
-
-
47349103031
-
Polymyalgia rheumatica and giant-cell arteritis
-
Salvarani C., Cantini F., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008, 372:234-245.
-
(2008)
Lancet
, vol.372
, pp. 234-245
-
-
Salvarani, C.1
Cantini, F.2
Hunder, G.G.3
-
2
-
-
77950311911
-
Increase in age at onset of giant cell arteritis: a population-based study
-
Kermani T.A., Schafer V.S., Crowson C.S., Hunder G.G., Gabriel S.E., Matteson E.L., et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis 2010, 69:780-781.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 780-781
-
-
Kermani, T.A.1
Schafer, V.S.2
Crowson, C.S.3
Hunder, G.G.4
Gabriel, S.E.5
Matteson, E.L.6
-
3
-
-
79953707617
-
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases
-
Crowson C.S., Matteson E.L., Myasoedova E., Michet C.J., Ernste F.C., Warrington K.J., et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 2011, 63:633-639.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 633-639
-
-
Crowson, C.S.1
Matteson, E.L.2
Myasoedova, E.3
Michet, C.J.4
Ernste, F.C.5
Warrington, K.J.6
-
4
-
-
0025103002
-
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
-
Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.
-
(1990)
Arthritis Rheum
, vol.33
, pp. 1122-1128
-
-
Hunder, G.G.1
Bloch, D.A.2
Michel, B.A.3
Stevens, M.B.4
Arend, W.P.5
Calabrese, L.H.6
-
5
-
-
79958020060
-
Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy
-
Walvick M.D., Walvick M.P. Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy. Ophthalmology 2011, 118(6):1201-1204.
-
(2011)
Ophthalmology
, vol.118
, Issue.6
, pp. 1201-1204
-
-
Walvick, M.D.1
Walvick, M.P.2
-
6
-
-
0030936381
-
Giant cell arteritis: validity and reliability of various diagnostic criteria
-
Hayreh S.S., Podhajsky P.A., Raman R., Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997, 123:285-296.
-
(1997)
Am J Ophthalmol
, vol.123
, pp. 285-296
-
-
Hayreh, S.S.1
Podhajsky, P.A.2
Raman, R.3
Zimmerman, B.4
-
7
-
-
0034787512
-
Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study
-
Salvarani C., Hunder G.G. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 2001, 45:140-145.
-
(2001)
Arthritis Rheum
, vol.45
, pp. 140-145
-
-
Salvarani, C.1
Hunder, G.G.2
-
8
-
-
33748975880
-
Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis
-
Parikh M., Miller N.R., Lee A.G., Savino P.J., Vacarezza M.N., Cornblath W., et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 2006, 113:1842-1845.
-
(2006)
Ophthalmology
, vol.113
, pp. 1842-1845
-
-
Parikh, M.1
Miller, N.R.2
Lee, A.G.3
Savino, P.J.4
Vacarezza, M.N.5
Cornblath, W.6
-
9
-
-
0037006117
-
Does this patient have temporal arteritis?
-
Smetana G.W., Shmerling R.H. Does this patient have temporal arteritis?. JAMA 2002, 287:92-101.
-
(2002)
JAMA
, vol.287
, pp. 92-101
-
-
Smetana, G.W.1
Shmerling, R.H.2
-
10
-
-
0020581078
-
The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome
-
Ellis M.E., Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 1983, 42:168-170.
-
(1983)
Ann Rheum Dis
, vol.42
, pp. 168-170
-
-
Ellis, M.E.1
Ralston, S.2
-
11
-
-
0024356859
-
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up
-
Kyle V., Cawston T.E., Hazleman B.L. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989, 48:667-671.
-
(1989)
Ann Rheum Dis
, vol.48
, pp. 667-671
-
-
Kyle, V.1
Cawston, T.E.2
Hazleman, B.L.3
-
12
-
-
0028174770
-
Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis
-
Pountain G.D., Calvin J., Hazleman B.L. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1994, 33:550-554.
-
(1994)
Br J Rheumatol
, vol.33
, pp. 550-554
-
-
Pountain, G.D.1
Calvin, J.2
Hazleman, B.L.3
-
13
-
-
0029857659
-
A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis
-
Myklebust G., Gran J.T. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996, 35:1161-1168.
-
(1996)
Br J Rheumatol
, vol.35
, pp. 1161-1168
-
-
Myklebust, G.1
Gran, J.T.2
-
14
-
-
19244368153
-
Giant cell arteritis with an erythrocyte sedimentation rate lower than 50
-
Martinez-Taboada V.M., Blanco R., Armona J., Uriarte E., Figueroa M., Gonzalez-Gay M.A., et al. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 2000, 19:73-75.
-
(2000)
Clin Rheumatol
, vol.19
, pp. 73-75
-
-
Martinez-Taboada, V.M.1
Blanco, R.2
Armona, J.3
Uriarte, E.4
Figueroa, M.5
Gonzalez-Gay, M.A.6
-
15
-
-
0031961899
-
Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis
-
Cid M.C., Font C., Oristrell J., de la Sierra A., Coll-Vinent B., Lopez-Soto A., et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998, 41:26-32.
-
(1998)
Arthritis Rheum
, vol.41
, pp. 26-32
-
-
Cid, M.C.1
Font, C.2
Oristrell, J.3
de la Sierra, A.4
Coll-Vinent, B.5
Lopez-Soto, A.6
|